Overview

MK0476 Study in Adult Patients With Acute Asthma (0476-322)

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast